BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3083802)

  • 1. Is the activation of aflatoxin B1 catalysed by the same form of cytochrome P-450 as that 4-hydroxylating debrisoquine in rat and/or man?
    Plummer S; Boobis AR; Davies DS
    Arch Toxicol; 1986 Feb; 58(3):165-70. PubMed ID: 3083802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aflatoxin B1 hydroxylation by the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microsomal cytochrome P-450.
    Halvorson MR; Safe SH; Parkinson A; Phillips TD
    Carcinogenesis; 1988 Nov; 9(11):2103-8. PubMed ID: 3141079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
    Shimada T; Nakamura S; Imaoka S; Funae Y
    Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole.
    Choi CY; Park SH; Park EH; Cha YN
    J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
    Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2(3)-tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytes.
    Ch'ih JJ; Biedrzycka DW; Lin T; Khoo MO; Devlin TM
    Proc Soc Exp Biol Med; 1989 Oct; 192(1):35-42. PubMed ID: 2508094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro.
    Metcalfe SA; Colley PJ; Neal GE
    Chem Biol Interact; 1981 May; 35(2):145-57. PubMed ID: 6783328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activation of aflatoxin B1 by P-450 HFLa in human fetal livers.
    Kitada M; Taneda M; Ohi H; Komori M; Itahashi K; Nagao M; Kamataki T
    Mutat Res; 1989 Sep; 227(1):53-8. PubMed ID: 2549412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of saturated and unsaturated dietary fat on aflatoxin B1 metabolism.
    Marzuki A; Norred WP
    Food Chem Toxicol; 1984 May; 22(5):383-9. PubMed ID: 6427082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
    Daniels JM; Massey TE
    Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin B1.
    Ueno Y; Ishii K; Omata Y; Kamataki T; Kato R
    Carcinogenesis; 1983 Aug; 4(8):1071-3. PubMed ID: 6409444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
    Stresser DM; Bailey GS; Williams DE
    Drug Metab Dispos; 1994; 22(3):383-91. PubMed ID: 8070314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary protein level on aflatoxin B1 actions in the liver of weanling rats.
    Mandel HG; Judah DJ; Neal GE
    Carcinogenesis; 1992 Oct; 13(10):1853-7. PubMed ID: 1423844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
    Raina V; Williams CJ; Gurtoo HL
    Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of aflatoxin B1 by liver tissue from male fischer F344 rats of various ages.
    Jayaraj A; Richardson A
    Mech Ageing Dev; 1981 Oct; 17(2):163-71. PubMed ID: 6273666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differences in the metabolic activation of aflatoxin B1 in the rat.
    Plummer S; Boobis AR; Davies DS
    Xenobiotica; 1987 Feb; 17(2):199-208. PubMed ID: 3105188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.